Speaker illustration

Associate Professor Ziad Hijazi

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)

Member of:

European Society of Cardiology

Ziad Hijazi, MD, PhD, Assoc. Professor Cardiology Ziad Hijazi is a faculty researcher at Uppsala Clinical Research Center (UCR) at Uppsala University and a senior consultant in cardiology at Uppsala University Hospital, Sweden. The research of Dr. Hijazi focuses on biomarkers, risk stratification, and antithrombotic treatment in atrial fibrillation. His formal research training includes a Ph.D. in medical sciences with emphasis on cardiovascular biomarkers in atrial fibrillation. He has participated in clinical events committees for many central large-scale multi-national clinical trials and chairs a number of subcommittees for biomarkers in clinical trials on new treatment interventions. Dr. Hijazi received his medical degree from Karolinska Institutet in Stockholm, Sweden.

Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention

Event: ESC CONGRESS 2019

Topic: Stroke Prevention

Session type: Practical Tutorials

Thumbnail

Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention

Event: ESC CONGRESS 2019

Topic: Stroke Prevention

Session type: Practical Tutorials

Thumbnail

This platform is supported by

logo Novo Nordisk